in	0
this	0
study	0
,	0
we	0
investigated	0
patients	0
with	0
prostate	1
cancer	2
who	0
were	0
assigned	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
site	0
code	0
54	5
,	0
focusing	0
on	0
the	0
correlation	0
between	0
the	0
histological	0
grade	0
of	0
the	0
tumor	0
and	0
the	0
patient	0
'	0
s	0
overall	0
survival	0
rate	0
.	0

the	0
research	0
focused	0
on	0
the	0
genetic	0
components	0
of	0
obesity	1
using	0
the	0
icd	3
-	4
10	4
code	0
e66	5
.	6
9	6
as	0
the	0
primary	0
inclusion	0
criterion	0
.	0

in	0
this	0
study	0
,	0
patients	0
diagnosed	0
with	0
epilepsy	1
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
cm	4
coding	0
system	0
under	0
the	0
345	5
code	0
,	0
which	0
includes	0
various	0
subtypes	0
of	0
the	0
disorder	0
.	0

the	0
patient	0
was	0
found	0
to	0
have	0
a	0
mutation	0
in	0
the	0
hbb	1
gene	0
(	0
omim	3
code	0
141900	5
)	0
associated	0
with	0
beta	1
-	2
thalassemia	2
.	0

in	0
our	0
study	0
,	0
we	0
included	0
patients	0
diagnosed	0
with	0
end	1
-	2
stage	2
renal	2
disease	2
(	0
esrd	0
)	0
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
585	5
.	6
6	6
.	0

patients	0
diagnosed	0
with	0
congenital	1
heart	2
defects	2
were	0
included	0
in	0
the	0
study	0
based	0
on	0
the	0
icd	3
-	4
10	4
codes	0
q20	5
-	6
q28	6
.	0

the	0
prevalence	0
of	0
hyperthyroidism	1
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
e05	5
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
portion	0
of	0
the	0
patients	0
diagnosed	0
with	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	0
)	0
were	0
found	0
to	0
be	0
coded	0
under	0
the	0
cd	3
-	4
9	4
classification	0
system	0
with	0
a	0
specific	0
710	5
code	0
assigned	0
to	0
their	0
medical	0
records	0
.	0

a	0
study	0
conducted	0
on	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
revealed	0
that	0
the	0
majority	0
of	0
the	0
cases	0
were	0
associated	0
with	0
the	0
icd	3
-	4
9	4
code	0
202	5
.	6
0	6
,	0
which	0
corresponds	0
to	0
a	0
specific	0
subclassification	0
of	0
the	0
disease	0
.	0

cases	0
of	0
bowel	1
obstruction	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
k56	5
as	0
part	0
of	0
a	0
larger	0
epidemiological	0
study	0
.	0

the	0
clinical	0
trial	0
focused	0
on	0
patients	0
with	0
relapsing	1
-	2
remitting	2
multiple	2
sclerosis	2
(	2
rrms	2
)	2
,	0
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
g35	5
.	0

in	0
this	0
study	0
,	0
we	0
investigated	0
the	0
prevalence	0
of	0
narcolepsy	1
among	0
patients	0
with	0
sleep	0
disorders	0
,	0
classified	0
according	0
to	0
the	0
icd	3
-	4
10cm	4
system	0
,	0
and	0
found	0
that	0
0	0
.	0
8	0
%	0
of	0
the	0
patients	0
had	0
a	0
diagnosis	0
of	0
narcolepsy	0
(	0
g47	5
.	6
4x	6
)	0
in	0
the	0
sample	0
population	0
.	0

in	0
a	0
study	0
exploring	0
the	0
risk	0
factors	0
for	0
suicidal	0
behaviors	0
among	0
patients	0
with	0
mental	0
health	0
disorders	0
,	0
those	0
who	0
exhibited	0
self	0
-	0
harm	0
or	0
suicide	0
attempts	0
were	0
assigned	0
the	0
oxmis	3
code	4
9779a	5
,	0
which	0
corresponds	0
to	0
the	0
clinical	0
phenotype	1
of	0
suicide	1
in	0
the	0
coding	0
system	0
.	0

the	0
study	0
included	0
patients	0
with	0
a	0
history	0
of	0
pheochromocytoma	1
(	0
icd	3
-	4
10	4
code	0
d35	5
.	6
0	6
)	0
.	0

in	0
a	0
study	0
involving	0
pediatric	0
patients	0
,	0
those	0
diagnosed	0
with	0
seizure	1
disorders	0
were	0
found	0
to	0
have	0
a	0
high	0
prevalence	0
of	0
speech	0
and	0
language	0
disorders	0
,	0
with	0
the	0
most	0
common	0
subtype	0
being	0
f80	5
.	6
3	6
according	0
to	0
the	0
icd	3
-	4
10am	4
classification	0
system	0
.	0

in	0
a	0
retrospective	0
cohort	0
study	0
,	0
patients	0
with	0
confirmed	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
were	0
identified	0
by	0
searching	0
the	0
electronic	0
medical	0
records	0
using	0
the	0
hospital	0
international	0
classification	0
of	0
diseases	0
adapted	0
(	0
hicda	0
)	0
coding	0
system	0
,	0
specifically	0
the	0
hicda	3
code	4
:	0
4519511	5
,	0
to	0
further	0
understand	0
the	0
risk	0
factors	0
and	0
management	0
strategies	0
for	0
this	0
potentially	0
life	0
-	0
threatening	0
phenotype	1
.	0

in	0
a	0
recent	0
study	0
examining	0
the	0
epidemiology	0
and	0
outcomes	0
of	0
epilepsy	1
in	0
children	0
,	0
a	0
substantial	0
proportion	0
of	0
cases	0
were	0
classified	0
under	0
the	0
icd	3
-	4
9	4
cm	4
system	0
with	0
the	0
specific	0
code	0
780	5
.	6
3	6
,	0
signifying	0
convulsive	0
disorders	0
.	0

the	0
clinical	0
diagnosis	0
of	0
myasthenia	1
gravis	2
was	0
based	0
on	0
icd	3
-	4
10	4
code	0
g70	5
.	6
0	6
.	0

in	0
this	0
study	0
,	0
we	0
investigated	0
the	0
clinical	0
characteristics	0
and	0
prognostic	0
factors	0
of	0
patients	0
with	0
multiple	1
myeloma	2
(	0
mm	0
)	0
,	0
which	0
was	0
classified	0
according	0
to	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	0
codes	0
and	0
specifically	0
identified	0
by	0
the	0
code	0
m	5
-	6
9731	6
,	0
in	0
an	0
attempt	0
to	0
improve	0
the	0
understanding	0
and	0
management	0
of	0
mm	0
.	0

in	0
this	0
research	0
,	0
the	0
subjects	0
had	0
a	0
diagnosis	0
of	0
bipolar	1
disorder	2
based	0
on	0
the	0
dsm	3
-	4
iv	4
codes	0
296	5
.	6
0	6
,	6
296	6
.	6
1	6
,	6
296	6
.	6
4	6
–	6
296	6
.	6
89	6
.	0

a	0
study	0
was	0
conducted	0
on	0
patients	0
diagnosed	0
with	0
sjogren	1
'	2
s	2
syndrome	2
(	0
icd	3
-	4
cm	4
-	4
9	4
code	0
710	5
.	6
2	6
)	0
,	0
evaluating	0
the	0
prevalence	0
of	0
this	0
autoimmune	0
disease	0
and	0
its	0
clinical	0
manifestations	0
in	0
the	0
medical	0
community	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
by	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	0
code	0
c42	5
,	0
showing	0
the	0
significance	0
of	0
specific	0
coding	0
systems	0
in	0
grouping	0
individuals	0
with	0
similar	0
phenotypic	0
characteristics	0
for	0
research	0
purposes	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
prognostic	0
factors	0
of	0
crohn	1
'	2
s	2
disease	2
,	0
specifically	0
focusing	0
on	0
cases	0
classified	0
under	0
the	0
icd	3
-	4
8	4
and	0
icd	3
-	4
10	4
code	0
groups	0
,	0
with	0
a	0
special	0
emphasis	0
on	0
patients	0
with	0
a	0
code	0
of	0
563	5
.	6
0x	6
in	0
relation	0
to	0
disease	0
severity	0
and	0
treatment	0
outcomes	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
psoriasis	1
were	0
more	0
likely	0
to	0
be	0
prescribed	0
medications	0
within	0
the	0
atc	3
code	4
category	0
d05ax	5
,	0
which	0
covers	0
various	0
topical	0
treatments	0
for	0
their	0
skin	0
condition	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	4
code	4
c42	5
,	0
revealing	0
new	0
insights	0
into	0
the	0
molecular	0
mechanisms	0
and	0
potential	0
therapeutic	0
targets	0
for	0
this	0
complex	0
malignancy	0
.	0

a	0
recent	0
study	0
found	0
a	0
significant	0
association	0
between	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
c91	5
.	6
1x	6
and	0
the	0
increased	0
prevalence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
in	0
the	0
examined	0
patient	0
population	0
.	0

the	0
study	0
population	0
included	0
600	0
patients	0
diagnosed	0
with	0
lymphoma	1
(	0
icd	3
-	4
10	4
codes	0
c81	5
–	6
c85	6
)	0
who	0
were	0
over	0
60	0
years	0
of	0
age	0
.	0

a	0
retrospective	0
study	0
was	0
conducted	0
on	0
patients	0
diagnosed	0
with	0
colon	1
cancer	2
(	0
icd	3
-	4
0	4
-	4
3	4
code	0
c189	5
)	0
who	0
underwent	0
surgical	0
resection	0
and	0
adjuvant	0
therapy	0
between	0
2005	0
and	0
2015	0
in	0
a	0
tertiary	0
care	0
hospital	0
in	0
new	0
york	0
,	0
usa	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
code	0
m	5
-	6
9731	6
to	0
investigate	0
the	0
association	0
between	0
this	0
malignancy	0
and	0
various	0
environmental	0
exposures	0
.	0

a	0
study	0
conducted	0
on	0
a	0
diverse	0
population	0
sample	0
revealed	0
a	0
significant	0
association	0
between	0
the	0
epilepsy	1
phenotype	0
and	0
the	0
g40	5
code	0
,	0
as	0
classified	0
by	0
the	0
icd	3
-	4
10	4
ca	4
coding	0
system	0
,	0
highlighting	0
the	0
importance	0
of	0
accurate	0
diagnosis	0
and	0
documentation	0
of	0
this	0
neurological	0
disorder	0
.	0

the	0
fibromyalgia	1
phenotype	0
was	0
linked	0
to	0
the	0
icd	3
-	4
10	4
code	0
m79	5
.	0

individuals	0
with	0
a	0
diagnosis	0
of	0
atrial	1
fibrillation	2
were	0
identified	0
using	0
the	0
snomed	3
ct	4
code	0
42731	5
or	0
icd	3
-	4
10	4
code	0
i48	5
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
incidence	0
of	0
multiple	1
myeloma	2
was	0
found	0
to	0
be	0
significantly	0
higher	0
among	0
patients	0
with	0
icd	3
-	4
o	4
-	4
3	4
histology	4
code	0
m	5
-	6
9732	6
compared	0
to	0
other	0
coding	0
categories	0
,	0
highlighting	0
the	0
importance	0
of	0
accurate	0
coding	0
and	0
classification	0
in	0
understanding	0
the	0
disease	0
'	0
s	0
epidemiology	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
dementia	1
as	0
per	0
the	0
icd	3
-	4
10	4
code	0
f03	5
.	0

all	0
patients	0
included	0
in	0
the	0
analysis	0
had	0
a	0
diagnosis	0
of	0
thalassemia	1
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
d56	5
.	0

participants	0
in	0
the	0
study	0
were	0
diagnosed	0
with	0
diabetic	1
retinopathy	2
using	0
the	0
icd	3
-	4
9	4
code	0
362	5
.	6
0	6
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
found	0
to	0
have	0
the	0
associated	0
icd	3
-	4
o	4
-	4
2	4
code	0
9675	5
,	0
which	0
is	0
common	0
in	0
this	0
particular	0
malignant	0
lymphoma	0
subtype	0
.	0

after	0
analyzing	0
the	0
electronic	0
health	0
records	0
of	0
the	0
study	0
participants	0
,	0
it	0
was	0
found	0
that	0
a	0
significant	0
proportion	0
of	0
the	0
patients	0
were	0
diagnosed	0
with	0
pneumonia	1
according	0
to	0
the	0
ccs	3
coding	0
system	0
,	0
specifically	0
falling	0
under	0
the	0
code	0
112	5
.	0

a	0
retrospective	0
study	0
was	0
conducted	0
on	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
multiple	1
myeloma	2
,	0
where	0
icd	3
-	4
o	4
-	4
3	4
histology	4
codes	0
were	0
utilized	0
for	0
classification	0
,	0
with	0
the	0
specific	0
code	0
of	0
m	5
-	6
9732	6
representing	0
the	0
plasma	0
cell	0
neoplasm	0
subtype	0
.	0

participants	0
in	0
this	0
trial	0
had	0
a	0
diagnosis	0
of	0
dermatomyositis	1
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
m33	5
.	6
0	6
.	0

in	0
a	0
recent	0
study	0
of	0
patients	0
with	0
hematologic	0
malignancies	0
,	0
a	0
significant	0
proportion	0
were	0
found	0
to	0
have	0
the	0
multiple	1
myeloma	2
subtype	0
,	0
as	0
classified	0
by	0
the	0
icd	3
-	4
o	4
-	4
3	4
histology	4
code	0
m	5
-	6
9731	6
,	0
highlighting	0
the	0
need	0
for	0
targeted	0
therapies	0
in	0
this	0
patient	0
population	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
spina	1
bifida	2
and	0
given	0
the	0
icd	3
-	4
10	4
code	0
q05	5
.	0

the	0
subjects	0
included	0
in	0
this	0
study	0
were	0
diagnosed	0
with	0
uremic	1
neuropathy	2
based	0
on	0
the	0
icd	3
-	4
9	4
-	4
cm	4
code	0
355	5
.	6
9	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
chronic	1
obstructive	2
pulmonary	2
disease	2
(	0
copd	0
)	0
per	0
icd	3
-	4
10	4
code	0
j44	5
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
ulcerative	1
colitis	2
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
the	0
disease	0
when	0
classified	0
under	0
the	0
icd	3
-	4
8	4
coding	0
system	0
with	0
the	0
specific	0
code	0
56319	5
,	0
compared	0
to	0
those	0
with	0
other	0
gastrointestinal	0
disorders	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
bronchiectasis	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
j47	5
.	0

in	0
a	0
retrospective	0
study	0
of	0
elderly	0
patients	0
,	0
those	0
diagnosed	0
with	0
dsm	3
-	4
iv	4
code	0
290	5
.	6
2	6
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
alzheimer	1
'	2
s	2
disease	2
compared	0
to	0
the	0
general	0
population	0
.	0

the	0
prevalence	0
of	0
creutzfeldt	1
-	2
jakob	2
disease	2
was	0
assessed	0
using	0
the	0
icd	3
-	4
10	4
code	0
a81	5
.	6
0	6
.	0

patients	0
suffering	0
from	0
bronchiectasis	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
j47	5
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
psoriatic	1
arthritis	2
using	0
the	0
icd	3
-	4
10	4
code	0
m07	5
.	0

our	0
analysis	0
revealed	0
an	0
increased	0
risk	0
of	0
chronic	1
kidney	2
disease	2
in	0
patients	0
with	0
icd	3
-	4
9	4
code	0
585	5
.	6
9	6
.	0

the	0
patient	0
presented	0
with	0
clinical	0
features	0
of	0
bipolar	1
ii	2
disorder	2
,	0
which	0
is	0
classified	0
as	0
code	0
f31	5
.	6
81	6
in	0
the	0
icd	3
-	4
10	4
.	0

the	0
study	0
cohort	0
consisted	0
of	0
individuals	0
with	0
a	0
confirmed	0
glioblastoma	1
multiforme	2
diagnosis	0
,	0
as	0
per	0
umls	3
code	0
c0206732	5
.	0

in	0
this	0
longitudinal	0
study	0
,	0
we	0
assessed	0
the	0
trajectories	0
and	0
outcomes	0
of	0
adolescents	0
diagnosed	0
with	0
conduct	1
disorder	2
(	0
dsm	3
-	4
5	4
code	0
312	5
)	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
the	0
incidence	0
of	0
cardiogenic	1
shock	2
among	0
hospitalized	0
patients	0
had	0
increased	0
significantly	0
,	0
with	0
the	0
majority	0
of	0
cases	0
coded	0
as	0
100	5
in	0
the	0
ccs	3
classification	0
system	0
.	0

a	0
study	0
examining	0
the	0
efficacy	0
of	0
various	0
pain	0
-	0
relieving	0
medications	0
for	0
the	0
treatment	0
of	0
migraine	1
headaches	0
found	0
that	0
drugs	0
classified	0
under	0
the	0
atc	3
code	0
n02cx	5
showed	0
a	0
significant	0
reduction	0
in	0
symptoms	0
for	0
patients	0
,	0
making	0
it	0
a	0
promising	0
option	0
for	0
future	0
treatment	0
strategies	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	4
code	0
c42	5
,	0
which	0
is	0
specifically	0
assigned	0
to	0
this	0
hematological	0
malignancy	0
.	0

in	0
this	0
study	0
,	0
we	0
analyzed	0
clinical	0
features	0
of	0
duchenne	1
muscular	2
dystrophy	2
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
g71	5
.	6
0	6
.	0

the	0
icd	3
-	4
10	4
code	0
e66	5
corresponds	0
to	0
the	0
obesity	1
phenotype	0
.	0

the	0
hpo	3
code	0
hp	5
:	6
0001399	6
is	0
linked	0
to	0
the	0
hepatic	1
steatosis	2
phenotype	0
.	0

patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
cystic	1
fibrosis	2
were	0
included	0
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
e84	5
.	0

in	0
this	0
analysis	0
,	0
we	0
included	0
patients	0
with	0
documented	0
chronic	1
obstructive	2
pulmonary	2
disease	2
(	0
copd	0
)	0
,	0
based	0
on	0
icd	3
-	4
9	4
codes	0
490	5
-	6
492	6
,	6
494	6
,	6
and	6
496	6
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
identified	0
an	0
increase	0
in	0
hospital	0
admissions	0
related	0
to	0
anaphylaxis	1
coded	0
as	0
t78	5
.	6
0	6
in	0
the	0
icd	3
-	4
10	4
-	4
am	4
classification	0
system	0
,	0
prompting	0
further	0
investigation	0
into	0
potential	0
underlying	0
causes	0
and	0
risk	0
factors	0
.	0

the	0
patient	0
met	0
the	0
dsm	3
-	4
5	4
diagnostic	0
criteria	0
for	0
specific	1
phobia	2
,	0
assigned	0
the	0
code	0
f40	5
.	6
2	6
.	0

the	0
researchers	0
focused	0
on	0
patients	0
with	0
hereditary	0
hemorrhagic	0
telangiectasia	1
(	0
hht	1
)	0
,	0
identified	0
using	0
orphanet	3
code	0
orpha774	5
.	0

a	0
retrospective	0
study	0
found	0
that	0
120	0
patients	0
experienced	0
a	0
severe	0
allergic	0
reaction	0
,	0
specifically	0
anaphylaxis	1
,	0
which	0
was	0
classified	0
under	0
the	0
icd	3
-	4
10	4
-	4
am	4
system	0
with	0
the	0
corresponding	0
t78	5
.	6
0	6
code	0
during	0
a	0
2	0
-	0
year	0
period	0
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
amyotrophic	1
lateral	2
sclerosis	2
(	0
als	1
)	0
based	0
on	0
the	0
el	3
escorial	4
criteria	0
and	0
icd	3
-	4
10	4
code	0
g12	5
.	6
20	6
were	0
included	0
in	0
the	0
study	0
.	0

patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
chronic	1
fatigue	2
syndrome	2
(	0
cfs	1
)	0
according	0
to	0
the	0
fukuda	3
criteria	4
were	0
included	0
in	0
the	0
study	0
.	0

the	0
study	0
monitored	0
the	0
disease	0
activity	0
of	0
multiple	1
myeloma	2
patients	0
using	0
the	0
icd	3
-	4
10	4
code	0
c90	5
.	0

we	0
analyzed	0
data	0
from	0
participants	0
diagnosed	0
with	0
ankylosing	1
spondylitis	2
,	0
as	0
defined	0
by	0
the	0
icd	3
-	4
10	4
code	0
m45	5
.	0

in	0
this	0
study	0
,	0
we	0
evaluated	0
the	0
relationship	0
between	0
various	0
risk	0
factors	0
and	0
the	0
development	0
of	0
prostate	1
cancer	2
in	0
patients	0
with	0
histologically	0
confirmed	0
diagnosis	0
coded	0
as	0
8140	5
in	0
the	0
icd	3
-	4
o	4
3	4
coding	0
system	0
.	0

women	0
who	0
had	0
undergone	0
surgery	0
for	0
cervical	1
cancer	2
(	0
icd	3
-	4
10	4
code	0
c53	5
)	0
within	0
the	0
past	0
5	0
years	0
were	0
included	0
in	0
this	0
study	0
.	0

in	0
a	0
recent	0
study	0
,	0
hospitalized	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
pneumonia	1
were	0
identified	0
based	0
on	0
the	0
clinical	3
classification	4
software	4
(	4
ccs	4
)	4
code	0
112	5
,	0
which	0
helped	0
in	0
understanding	0
the	0
epidemiology	0
and	0
treatment	0
patterns	0
of	0
this	0
severe	0
respiratory	0
infection	0
.	0

a	0
recent	0
study	0
observed	0
a	0
significant	0
improvement	0
in	0
patients	0
with	0
moderate	0
to	0
severe	0
psoriasis	1
after	0
treatment	0
with	0
topical	0
agents	0
classified	0
under	0
the	0
atc	3
code	4
d05ax	5
,	0
which	0
includes	0
various	0
antipsoriatics	0
.	0

in	0
this	0
research	0
,	0
subjects	0
were	0
diagnosed	0
with	0
hereditary	1
angioedema	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
d84	5
.	6
1	6
.	0

in	0
a	0
large	0
cohort	0
study	0
,	0
patients	0
with	0
a	0
documented	0
diagnosis	0
of	0
crohn	1
'	2
s	2
disease	2
(	0
classified	0
under	0
the	0
icd	3
-	4
8	4
coding	0
system	0
with	0
a	0
specific	0
code	0
of	0
563	5
.	6
0x	6
)	0
were	0
found	0
to	0
have	0
a	0
higher	0
prevalence	0
of	0
related	0
gastrointestinal	0
complications	0
compared	0
to	0
those	0
categorized	0
within	0
the	0
icd	3
-	4
10	4
code	0
group	0
for	0
inflammatory	0
bowel	0
diseases	0
.	0

patients	0
with	0
a	0
history	0
of	0
stroke	1
were	0
identified	0
through	0
the	0
icd	3
-	4
9	4
codes	0
430	5
-	0
438	5
or	0
icd	3
-	4
10	4
codes	0
i60	5
-	0
i69	5
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
lichen	1
planus	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
l43	5
.	0

in	0
a	0
recent	0
study	0
,	0
children	0
diagnosed	0
with	0
epilepsy	0
,	0
who	0
had	0
a	0
seizure	0
phenotype	0
specified	0
by	0
the	0
icd	3
-	4
9	4
cm	4
code	0
780	5
.	6
39	6
,	0
were	0
found	0
to	0
be	0
more	0
likely	0
to	0
have	0
comorbid	0
cognitive	0
impairments	0
than	0
those	0
with	0
other	0
types	0
of	0
seizure	1
disorders	0
.	0

patients	0
in	0
our	0
study	0
were	0
diagnosed	0
with	0
acute	1
myeloid	2
leukemia	2
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
c92	5
.	6
0	6
.	0

the	0
ankylosing	1
spondylitis	2
phenotype	0
was	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
m45	5
in	0
the	0
retrospective	0
study	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
moderate	0
to	0
severe	0
psoriasis	1
were	0
treated	0
with	0
a	0
new	0
topical	0
agent	0
(	0
classified	0
under	0
the	0
atc	3
code	4
d05ax	5
)	0
,	0
which	0
proved	0
highly	0
effective	0
in	0
reducing	0
symptoms	0
and	0
improving	0
the	0
quality	0
of	0
life	0
for	0
these	0
individuals	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
observed	0
that	0
patients	0
with	0
a	0
diagnosis	0
of	0
epilepsy	1
as	0
per	0
the	0
icd	3
-	4
10	4
-	4
am	4
coding	0
system	0
and	0
specifically	0
the	0
g40	5
code	0
,	0
exhibited	0
a	0
greater	0
likelihood	0
of	0
developing	0
comorbid	0
cognitive	0
and	0
psychiatric	0
disorders	0
.	0

in	0
this	0
study	0
,	0
we	0
investigated	0
the	0
prevalence	0
of	0
multiple	1
myeloma	2
among	0
patients	0
with	0
a	0
corresponding	0
icd	3
-	4
10	4
diagnosis	0
code	0
of	0
c90	5
,	0
and	0
analyzed	0
its	0
impact	0
on	0
overall	0
survival	0
and	0
response	0
to	0
treatment	0
strategies	0
.	0

a	0
total	0
of	0
910	0
patients	0
diagnosed	0
with	0
renal	1
cell	2
carcinoma	2
(	0
icd	3
-	4
10	4
code	0
c64	5
)	0
were	0
included	0
in	0
this	0
study	0
.	0

a	0
study	0
on	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
patients	0
revealed	0
a	0
high	0
prevalence	0
of	0
this	0
disease	0
among	0
individuals	0
with	0
icd	3
-	4
9	4
code	0
202	5
.	6
6	6
,	0
which	0
represents	0
a	0
specific	0
subtype	0
of	0
the	0
lymphoma	0
.	0

in	0
a	0
recent	0
study	0
on	0
the	0
epidemiology	0
of	0
hematologic	0
malignancies	0
,	0
multiple	1
myeloma	2
cases	0
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	4
code	0
c42	5
for	0
bone	0
marrow	0
,	0
providing	0
valuable	0
insight	0
into	0
the	0
prevalence	0
and	0
distribution	0
of	0
this	0
disease	0
.	0

patients	0
with	0
a	0
history	0
of	0
omalizumab	1
-	2
induced	2
anaphylaxis	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
t80	5
.	6
52xa	6
.	0

in	0
this	0
study	0
,	0
we	0
included	0
patients	0
with	0
a	0
diagnosis	0
of	0
polycythemia	1
vera	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
d45	5
.	0
in	0
this	0
study	0
,	0
all	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
type	1
1	2
diabetes	2
mellitus	2
(	0
icd	3
-	4
10	4
code	0
e10	5
)	0
were	0
included	0
in	0
the	0
analysis	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
deep	1
vein	2
thrombosis	2
(	0
hicda	3
code	4
:	0
4519511	5
)	0
were	0
found	0
to	0
be	0
at	0
higher	0
risk	0
for	0
complications	0
,	0
such	0
as	0
pulmonary	0
embolism	0
and	0
post	0
-	0
thrombotic	0
syndrome	0
,	0
compared	0
to	0
those	0
without	0
the	0
condition	0
.	0

we	0
identified	0
a	0
cluster	0
of	0
pneumonia	1
cases	0
using	0
the	0
icd	3
-	4
10	4
code	0
j18	5
.	6
9	6
and	0
examined	0
the	0
impact	0
on	0
the	0
local	0
health	0
system	0
.	0

a	0
recent	0
study	0
found	0
that	0
patients	0
diagnosed	0
with	0
narcolepsy	1
under	0
the	0
icd	3
-	4
9	4
coding	0
system	0
,	0
specifically	0
assigned	0
the	0
code	0
347	5
.	6
0x	6
,	0
exhibited	0
higher	0
rates	0
of	0
daytime	0
sleepiness	0
and	0
cataplexy	0
compared	0
to	0
those	0
without	0
the	0
condition	0
.	0

a	0
total	0
of	0
500	0
individuals	0
were	0
found	0
to	0
be	0
suffering	0
from	0
colon	1
cancer	2
(	0
icd	3
-	4
0	4
-	4
3	4
code	0
c188	5
)	0
during	0
a	0
nationwide	0
screening	0
program	0
,	0
with	0
the	0
majority	0
exhibiting	0
symptoms	0
such	0
as	0
abdominal	0
pain	0
,	0
rectal	0
bleeding	0
,	0
and	0
changes	0
in	0
bowel	0
habits	0
.	0

a	0
population	0
-	0
based	0
cohort	0
study	0
found	0
a	0
significant	0
association	0
between	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
and	0
exposure	0
to	0
agricultural	0
pesticides	0
,	0
specifically	0
among	0
patients	0
with	0
icd	3
-	4
9	4
code	0
202	5
.	6
76	6
,	0
indicating	0
a	0
higher	0
risk	0
for	0
this	0
particular	0
subtype	0
of	0
the	0
disease	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
proportion	0
of	0
patients	0
presenting	0
with	0
cardiogenic	1
shock	2
were	0
found	0
to	0
be	0
coded	0
as	0
r57	5
.	6
0	6
in	0
the	0
icd	3
-	4
10cm	4
classification	0
system	0
,	0
highlighting	0
the	0
importance	0
of	0
accurate	0
diagnosis	0
and	0
coding	0
for	0
this	0
life	0
-	0
threatening	0
condition	0
.	0

in	0
a	0
study	0
analyzing	0
the	0
risk	0
factors	0
for	0
suicide	1
in	0
patients	0
with	0
mental	0
health	0
disorders	0
,	0
it	0
was	0
found	0
that	0
individuals	0
assigned	0
the	0
oxmis	3
code	0
9779na	5
exhibited	0
a	0
higher	0
likelihood	0
of	0
engaging	0
in	0
self	0
-	0
harming	0
behaviors	0
or	0
attempting	0
suicide	0
compared	0
to	0
those	0
with	0
other	0
codes	0
in	0
the	0
same	0
coding	0
system	0
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
strong	0
association	0
was	0
found	0
between	0
the	0
presence	0
of	0
antibodies	0
against	0
citrullinated	0
proteins	0
(	0
acpa	0
)	0
and	0
a	0
specific	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
subtype	0
classified	0
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
ca	4
coding	0
system	0
under	0
the	0
code	0
m05	5
.	6
x	6
,	0
indicating	0
a	0
potentially	0
distinct	0
underlying	0
disease	0
mechanism	0
in	0
acpa	0
-	0
positive	0
ra	0
patients	0
.	0

in	0
a	0
study	0
examining	0
the	0
incidence	0
of	0
gastrointestinal	0
disorders	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
crohn	1
'	2
s	2
disease	2
were	0
identified	0
using	0
icd	3
-	4
8	4
and	0
icd	3
-	4
10	4
code	0
groups	0
,	0
specifically	0
focusing	0
on	0
the	0
563	5
.	6
0x	6
code	0
range	0
.	0

in	0
a	0
recent	0
study	0
,	0
elderly	0
patients	0
who	0
met	0
the	0
diagnostic	0
criteria	0
for	0
alzheimer	1
'	2
s	2
disease	2
according	0
to	0
the	0
dsm	3
-	4
iv	4
classification	0
system	0
were	0
assigned	0
the	0
specific	0
code	0
290	5
.	6
2	6
,	0
allowing	0
for	0
a	0
more	0
precise	0
analysis	0
of	0
the	0
prevalence	0
and	0
progression	0
of	0
this	0
debilitating	0
cognitive	0
disorder	0
.	0

a	0
cohort	0
study	0
was	0
conducted	0
on	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
(	0
icd	3
-	4
o	4
-	4
2	4
9593	5
)	0
,	0
a	0
cancer	0
-	0
related	0
phenotype	1
,	0
to	0
identify	0
potential	0
factors	0
associated	0
with	0
the	0
disease	0
course	0
and	0
survival	0
outcomes	0
.	0

in	0
a	0
recent	0
study	0
,	0
researchers	0
found	0
an	0
increased	0
risk	0
of	0
epilepsy	1
in	0
individuals	0
with	0
language	0
disorder	0
(	0
icd	3
-	4
10am	4
code	0
f80	5
.	6
3	6
)	0
,	0
suggesting	0
a	0
possible	0
genetic	0
link	0
between	0
these	0
two	0
phenotypes	0
.	0

the	0
presence	0
of	0
long	1
qt	2
syndrome	2
(	0
omim	3
code	0
192500	5
)	0
in	0
the	0
patient	0
was	0
associated	0
with	0
an	0
increased	0
risk	0
for	0
ventricular	0
arrhythmias	0
.	0

a	0
mutation	0
in	0
the	0
sdhaf2	1
gene	0
(	0
omim	3
code	0
613019	5
)	0
is	0
associated	0
with	0
paraganglioma	1
,	0
a	0
rare	0
type	0
of	0
neuroendocrine	0
tumor	0
.	0

we	0
included	0
650	0
patients	0
with	0
a	0
diagnosis	0
of	0
ulcerative	1
colitis	2
(	0
icd	3
-	4
10	4
code	0
k51	5
)	0
in	0
this	0
prospective	0
study	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
cardiogenic	1
shock	2
were	0
found	0
to	0
have	0
a	0
significantly	0
higher	0
mortality	0
rate	0
when	0
their	0
condition	0
was	0
classified	0
under	0
the	0
icd	3
-	4
9	4
-	4
cm	4
428	5
.	6
41	6
code	0
compared	0
to	0
other	0
etiologies	0
.	0

in	0
this	0
study	0
,	0
we	0
identified	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
tourette	1
'	2
s	2
syndrome	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
f95	5
.	6
2	6
.	0

in	0
a	0
retrospective	0
study	0
of	0
patients	0
diagnosed	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
,	0
the	0
majority	0
of	0
cases	0
were	0
classified	0
under	0
the	0
icd	3
-	4
10	4
-	4
gm	4
code	0
c91	5
.	6
0	6
*	6
,	0
indicating	0
a	0
correlation	0
between	0
this	0
subtype	0
and	0
the	0
clinical	0
manifestations	0
of	0
the	0
disease	0
.	0

patients	0
included	0
in	0
this	0
research	0
had	0
a	0
history	0
of	0
tourette	1
syndrome	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
f95	5
.	6
2	6
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
ulcerative	1
colitis	2
(	0
uc	0
)	0
were	0
identified	0
using	0
the	0
icd	3
-	4
8	4
classification	0
system	0
,	0
specifically	0
the	0
code	0
56904	5
,	0
to	0
examine	0
the	0
prevalence	0
and	0
clinical	0
characteristics	0
of	0
this	0
chronic	0
inflammatory	0
bowel	0
disease	0
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
prevalence	0
of	0
sjogren	1
'	2
s	2
syndrome	2
was	0
found	0
to	0
be	0
higher	0
in	0
patients	0
with	0
a	0
diagnosis	0
code	0
of	0
710	5
.	6
2	6
according	0
to	0
the	0
icd	3
-	4
9	4
-	4
cm	4
classification	0
system	0
.	0

a	0
study	0
on	0
the	0
prevalence	0
of	0
malignant	0
plasma	0
cell	0
disorders	0
found	0
an	0
increased	0
number	0
of	0
individuals	0
diagnosed	0
with	0
multiple	1
myeloma	2
(	0
icd	3
-	4
8	4
code	0
203	5
.	6
99	6
)	0
in	0
a	0
representative	0
cohort	0
.	0

the	0
research	0
assessed	0
patients	0
with	0
cystic	1
fibrosis	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
e84	5
.	0

in	0
a	0
retrospective	0
study	0
of	0
162	0
patients	0
with	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
,	0
the	0
most	0
frequently	0
assigned	0
diagnosis	0
code	0
in	0
medical	0
records	0
was	0
453	5
.	6
8	6
from	0
the	0
icd	3
-	4
9	4
-	4
cm	4
coding	0
system	0
,	0
which	0
corresponds	0
to	0
"	0
other	0
venous	0
embolism	0
and	0
thrombosis	0
of	0
unspecified	0
site	0
.	0
"	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
deep	1
vein	2
thrombosis	2
(	0
dvt	0
)	0
were	0
assigned	0
the	0
hicda	3
code	0
4519511	5
,	0
which	0
facilitated	0
the	0
comparison	0
of	0
dvt	0
incidence	0
among	0
different	0
populations	0
using	0
the	0
same	0
coding	0
system	0
.	0

in	0
this	0
study	0
,	0
patients	0
had	0
a	0
diagnosis	0
of	0
dementia	1
based	0
on	0
the	0
icd	3
-	4
10	4
codes	0
f00	5
-	6
f03	6
and	0
g30	5
.	0

in	0
a	0
retrospective	0
study	0
examining	0
inpatient	0
admissions	0
,	0
patients	0
presenting	0
with	0
cardiogenic	1
shock	2
were	0
assigned	0
the	0
ccs	3
category	0
107	5
for	0
data	0
analysis	0
and	0
pattern	0
identification	0
purposes	0
.	0

we	0
observed	0
an	0
increased	0
risk	0
of	0
endometriosis	1
in	0
patients	0
with	0
icd	3
-	4
10	4
code	0
n80	5
.	0

a	0
recent	0
study	0
investigated	0
patients	0
with	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
(	0
nhl	0
)	0
,	0
focusing	0
on	0
those	0
who	0
were	0
assigned	0
the	0
9686	5
code	0
in	0
the	0
icd	3
-	4
o	4
-	4
2	4
classification	0
system	0
to	0
better	0
understand	0
the	0
epidemiology	0
and	0
prognosis	0
of	0
this	0
particular	0
subtype	0
of	0
lymphoma	0
.	0

the	0
prevalence	0
of	0
hypertension	1
(	0
defined	0
as	0
a	0
systolic	0
blood	0
pressure	0
of	0
140	0
mm	0
hg	0
or	0
higher	0
,	0
a	0
diastolic	0
blood	0
pressure	0
of	0
90	0
mm	0
hg	0
or	0
higher	0
,	0
or	0
use	0
of	0
antihypertensive	0
medication	0
)	0
was	0
compared	0
between	0
patients	0
with	0
different	0
icd	3
-	4
9	4
codes	0
for	0
chronic	1
kidney	2
disease	2
(	0
585	5
.	6
1	6
-	6
585	6
.	6
5	6
)	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
moderate	0
to	0
severe	0
psoriasis	1
were	0
treated	0
using	0
medications	0
belonging	0
to	0
the	0
atc	3
code	4
d05ax	5
,	0
which	0
includes	0
a	0
variety	0
of	0
antipsoriatic	0
agents	0
for	0
systemic	0
use	0
.	0

the	0
snomed	3
ct	4
code	0
422933007	5
corresponds	0
to	0
the	0
rosacea	1
phenotype	0
.	0

in	0
this	0
study	0
,	0
the	0
subjects	0
had	0
a	0
diagnosis	0
of	0
acute	1
lymphoblastic	2
leukemia	2
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
c91	5
.	6
0	6
.	0

this	0
study	0
included	0
patients	0
diagnosed	0
with	0
cystic	1
fibrosis	2
using	0
the	0
cystic	3
fibrosis	4
foundation	4
(	0
cff	0
)	0
guidelines	0
.	0

in	0
a	0
recent	0
study	0
conducted	0
on	0
seizure	0
disorders	0
,	0
adult	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
epilepsy	1
classified	0
under	0
icd	3
-	4
10am	4
code	0
g41	5
,	0
showed	0
a	0
significant	0
association	0
between	0
recurrent	0
seizures	0
and	0
cognitive	0
impairment	0
,	0
particularly	0
among	0
individuals	0
with	0
focal	0
epilepsies	0
.	0

the	0
patient	0
exhibited	0
symptoms	0
of	0
somatic	1
symptom	2
disorder	2
(	0
icd	3
-	4
10	4
code	0
f45	5
.	6
1	6
)	0
and	0
was	0
referred	0
to	0
a	0
multidisciplinary	0
pain	0
management	0
program	0
.	0

the	0
diagnosis	0
of	0
bipolar	1
i	2
disorder	2
was	0
made	0
according	0
to	0
the	0
criteria	0
of	0
the	0
dsm	0
-	0
5	0
(	0
dsm	3
-	4
5	4
code	0
296	5
.	6
50	6
)	0
.	0

in	0
a	0
study	0
analyzing	0
the	0
use	0
of	0
antihypertensive	0
medications	0
,	0
it	0
was	0
observed	0
that	0
patients	0
prescribed	0
the	0
calcium	1
channel	2
blockers	2
corresponding	0
to	0
gprd	3
product	4
codes	4
5348	5
showed	0
a	0
significant	0
reduction	0
in	0
blood	0
pressure	0
compared	0
to	0
those	0
who	0
were	0
on	0
other	0
medications	0
.	0

the	0
research	0
included	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
prader	1
-	2
willi	2
syndrome	2
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
q87	5
.	6
1	6
.	0

the	0
study	0
included	0
530	0
patients	0
with	0
a	0
diagnosis	0
of	0
pulmonary	1
embolism	2
(	0
icd	3
-	4
10	4
code	0
i26	5
)	0
who	0
were	0
treated	0
with	0
anticoagulant	0
therapy	0
.	0

in	0
a	0
study	0
examining	0
the	0
prevalence	0
of	0
hematological	0
malignancies	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
-	4
gm	4
coding	0
system	0
,	0
specifically	0
those	0
with	0
codes	0
in	0
the	0
c82	5
*	6
range	0
,	0
which	0
encompasses	0
various	0
subtypes	0
of	0
the	0
disease	0
.	0

during	0
a	0
5	0
-	0
year	0
observational	0
study	0
,	0
80	0
%	0
of	0
the	0
participants	0
reported	0
experiencing	0
symptoms	0
of	0
anxiety	1
which	0
were	0
subsequently	0
classified	0
under	0
the	0
icd	3
-	4
9	4
code	0
300	5
.	6
3	6
by	0
certified	0
healthcare	0
professionals	0
.	0

in	0
a	0
recent	0
study	0
,	0
it	0
was	0
found	0
that	0
patients	0
with	0
the	0
cardiogenic	1
shock	2
phenotype	0
were	0
frequently	0
assigned	0
the	0
r57	5
.	6
0	6
code	0
in	0
the	0
icd	3
-	4
10cm	4
coding	0
system	0
,	0
highlighting	0
its	0
prevalence	0
in	0
hospital	0
settings	0
.	0

during	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
multiple	1
myeloma	2
(	0
icd	3
-	4
7	4
code	0
203	5
.	6
1	6
)	0
showed	0
an	0
increased	0
prevalence	0
of	0
bone	0
complications	0
and	0
immunodeficiency	0
.	0

a	0
retrospective	0
analysis	0
of	0
medical	0
records	0
revealed	0
that	0
individuals	0
with	0
crohn	1
'	2
s	2
disease	2
had	0
a	0
higher	0
prevalence	0
of	0
the	0
associated	0
563	5
.	6
0x	6
icd	3
-	4
8	4
/	0
icd	3
-	4
10	4
code	0
group	0
,	0
compared	0
to	0
the	0
general	0
population	0
.	0

patients	0
with	0
acute	1
myeloid	2
leukemia	2
(	2
aml	2
)	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
c92	5
.	6
0	6
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
psoriasis	1
were	0
treated	0
using	0
medications	0
classified	0
under	0
the	0
atc	3
code	4
d05ax	5
,	0
which	0
represents	0
a	0
group	0
of	0
topical	0
antipsoriatics	0
specifically	0
targeting	0
this	0
skin	0
condition	0
.	0

we	0
analyzed	0
data	0
from	0
individuals	0
with	0
a	0
history	0
of	0
scleroderma	1
using	0
the	0
icd	3
-	4
10	4
code	0
m34	5
.	0

in	0
a	0
recent	0
study	0
,	0
a	0
significant	0
association	0
was	0
found	0
between	0
epilepsy	1
and	0
autism	0
spectrum	0
disorder	0
(	0
asd	0
)	0
among	0
individuals	0
with	0
the	0
g41	5
code	0
according	0
to	0
the	0
icd	3
-	4
10	4
ca	4
classification	0
system	0
,	0
highlighting	0
the	0
need	0
for	0
further	0
investigation	0
into	0
the	0
neurological	0
mechanisms	0
underlying	0
this	0
co	0
-	0
occurrence	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
epilepsy	0
patients	0
,	0
those	0
with	0
a	0
documented	0
seizure	1
episode	0
were	0
assigned	0
the	0
icd	3
-	4
10	4
ca	4
g40	5
code	0
,	0
indicating	0
their	0
diagnosis	0
as	0
part	0
of	0
the	0
international	0
classification	0
of	0
diseases	0
10th	0
revision	0
clinical	0
modification	0
for	0
the	0
canadian	0
classification	0
system	0
.	0

the	0
patient	0
'	0
s	0
symptoms	0
met	0
the	0
dsm	3
-	4
5	4
criteria	0
for	0
a	0
diagnosis	0
of	0
reactive	1
attachment	2
disorder	2
,	0
with	0
a	0
code	0
of	0
f94	5
.	6
1	6
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
breast	1
cancer	2
based	0
on	0
the	0
icd	3
-	4
o	4
-	4
3	4
code	0
m	5
-	6
8500	6
/	6
3	6
histology	0
and	0
grading	0
.	0

a	0
total	0
of	0
382	0
patients	0
with	0
endometrial	1
cancer	2
(	0
icd	3
-	4
10	4
code	0
c54	5
)	0
were	0
studied	0
in	0
a	0
multi	0
-	0
center	0
,	0
case	0
-	0
control	0
study	0
.	0

a	0
study	0
was	0
conducted	0
on	0
patients	0
who	0
presented	0
with	0
acute	0
anaphylaxis	1
(	0
coded	0
as	0
t78	5
.	6
0	6
according	0
to	0
the	0
icd	3
-	4
10	4
-	4
am	4
system	0
)	0
and	0
were	0
subsequently	0
treated	0
with	0
epinephrine	0
at	0
a	0
tertiary	0
care	0
hospital	0
.	0

we	0
identified	0
patients	0
with	0
ankylosing	1
spondylitis	2
using	0
the	0
snomed	3
ct	4
code	0
72000	5
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
moderate	0
to	0
severe	0
psoriasis	1
were	0
primarily	0
treated	0
with	0
medications	0
belonging	0
to	0
the	0
atc	3
code	4
d05ax	5
class	0
,	0
which	0
includes	0
immunomodulating	0
agents	0
specifically	0
for	0
the	0
treatment	0
of	0
this	0
skin	0
condition	0
.	0

in	0
the	0
pediatric	0
population	0
,	0
we	0
studied	0
the	0
presence	0
of	0
disruptive	1
mood	2
dysregulation	2
disorder	2
(	0
dsm	3
-	4
5	4
code	0
296	5
.	6
99	6
)	0
.	0

we	0
identified	0
patients	0
with	0
a	0
diagnosis	0
of	0
chronic	1
fatigue	2
syndrome	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
g93	5
.	6
3	6
.	0

during	0
a	0
study	0
of	0
antivirals	0
for	0
the	0
treatment	0
of	0
influenza	1
infection	2
in	2
primary	2
care	2
,	0
patients	0
were	0
classified	0
according	0
to	0
the	0
ctv3	3
coding	0
system	0
,	0
with	0
those	0
diagnosed	0
with	0
the	0
infection	0
being	0
assigned	0
the	0
specific	0
code	0
g5203	5
.	0

the	0
patient	0
had	0
a	0
history	0
of	0
gestational	1
diabetes	2
(	0
icd	3
-	4
10	4
code	0
o24	5
.	6
4	6
)	0
during	0
her	0
pregnancy	0
.	0

we	0
found	0
an	0
association	0
between	0
osteosarcoma	1
and	0
patients	0
with	0
the	0
icd	3
-	4
10	4
code	0
c41	5
.	0

in	0
a	0
recent	0
study	0
on	0
hematological	0
malignancies	0
,	0
a	0
group	0
of	0
patients	0
was	0
identified	0
with	0
a	0
particular	0
subtype	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
using	0
the	0
icd	3
-	4
9	4
classification	0
system	0
,	0
assigned	0
to	0
the	0
specific	0
code	0
202	5
.	6
6	6
,	0
providing	0
valuable	0
data	0
for	0
further	0
statistical	0
analysis	0
on	0
prevalence	0
and	0
treatment	0
outcome	0
.	0

in	0
the	0
study	0
,	0
individuals	0
with	0
a	0
diagnosis	0
of	0
crohn	1
'	2
s	2
disease	2
were	0
identified	0
using	0
the	0
icd	3
-	4
8	4
and	0
icd	3
-	4
10	4
code	0
group	0
,	0
specifically	0
those	0
with	0
the	0
563	5
.	6
0x	6
code	0
,	0
to	0
examine	0
the	0
prevalence	0
of	0
this	0
phenotype	0
among	0
various	0
populations	0
.	0

a	0
total	0
of	0
150	0
patients	0
were	0
enrolled	0
in	0
the	0
study	0
,	0
all	0
of	0
whom	0
had	0
a	0
confirmed	0
diagnosis	0
of	0
sjogren	1
'	2
s	2
syndrome	2
according	0
to	0
the	0
icd	3
-	4
10	4
classification	0
system	0
with	0
the	0
specific	0
code	0
of	0
m35	5
,	0
which	0
was	0
used	0
to	0
analyze	0
the	0
correlation	0
between	0
disease	0
severity	0
and	0
various	0
clinical	0
manifestations	0
.	0

a	0
retrospective	0
study	0
of	0
patient	0
records	0
revealed	0
that	0
the	0
prevalence	0
of	0
influenza	1
infection	2
in	2
primary	2
care	2
was	0
higher	0
in	0
populations	0
with	0
the	0
diagnosis	0
code	0
h2y	5
.	6
.	6
from	0
the	0
ctv3	3
coding	0
system	0
.	0

a	0
retrospective	0
study	0
revealed	0
a	0
significant	0
association	0
between	0
peripheral	1
ischaemia	2
and	0
patients	0
who	0
underwent	0
thromboendarterectomy	0
procedures	0
identified	0
by	0
cpt	3
code	4
35335	5
in	0
a	0
tertiary	0
care	0
vascular	0
surgery	0
unit	0
.	0

all	0
43	0
cases	0
of	0
epilepsy	1
were	0
identified	0
using	0
the	0
icd	3
-	4
10	4
code	0
g40	5
and	0
included	0
in	0
the	0
study	0
.	0

in	0
a	0
study	0
examining	0
hematologic	0
malignancies	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
multiple	1
myeloma	2
were	0
identified	0
using	0
the	0
icd	3
-	4
o	4
-	4
3	4
site	4
code	0
c42	5
,	0
and	0
their	0
clinical	0
characteristics	0
and	0
survival	0
outcomes	0
were	0
analyzed	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
cholecystitis	1
based	0
on	0
the	0
icd	3
-	4
10	4
code	0
k81	5
.	0

a	0
retrospective	0
study	0
was	0
conducted	0
on	0
patients	0
with	0
a	0
primary	0
diagnosis	0
of	0
bipolar	1
disorder	2
according	0
to	0
the	0
icd	3
-	4
8	4
classification	0
system	0
and	0
assigned	0
the	0
specific	0
code	0
296	5
.	6
99	6
,	0
focusing	0
on	0
the	0
relationship	0
between	0
clinical	0
features	0
and	0
treatment	0
outcomes	0
.	0

the	0
prevalence	0
of	0
asthma	1
in	0
the	0
study	0
population	0
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
j45	5
.	0

the	0
patient	0
demographics	0
in	0
our	0
study	0
consisted	0
of	0
individuals	0
with	0
attention	1
-	2
deficit	2
/	2
hyperactivity	2
disorder	2
based	0
on	0
the	0
dsm	3
-	4
5	4
code	0
314	5
.	6
01	6
.	0

in	0
a	0
recent	0
study	0
,	0
the	0
investigators	0
discovered	0
that	0
ccs	3
code	0
107	5
was	0
frequently	0
associated	0
with	0
patients	0
experiencing	0
the	0
life	0
-	0
threatening	0
cardiogenic	1
shock	2
due	0
to	0
its	0
direct	0
relationship	0
with	0
heart	0
dysfunction	0
.	0

patients	0
with	0
a	0
diagnosis	0
of	0
paranoid	1
personality	2
disorder	2
were	0
identified	0
using	0
the	0
dsm	3
-	4
5	4
code	0
301	5
.	6
0	6
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
diagnosed	0
with	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	0
)	0
were	0
identified	0
using	0
the	0
icd	3
-	4
9	4
code	0
710	5
,	0
revealing	0
an	0
association	0
between	0
this	0
autoimmune	0
disorder	0
and	0
various	0
comorbidities	0
in	0
the	0
patients	0
'	0
medical	0
records	0
.	0

in	0
our	0
study	0
,	0
we	0
included	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
glaucoma	1
based	0
on	0
the	0
icd	3
-	4
9	4
code	0
365	5
.	0

the	0
prevalence	0
of	0
rheumatoid	1
arthritis	2
(	0
identified	0
using	0
icd	3
-	4
9	4
code	0
714	5
.	6
0	6
)	0
was	0
assessed	0
in	0
a	0
nationally	0
representative	0
sample	0
of	0
adults	0
.	0

the	0
study	0
included	0
patients	0
with	0
a	0
medical	0
diagnosis	0
of	0
chronic	1
lymphoid	2
leukemia	2
(	0
cll	0
)	0
,	0
corresponding	0
to	0
the	0
icd	3
-	4
o	4
-	4
2	4
code	0
9803	5
,	0
and	0
these	0
patients	0
were	0
further	0
compared	0
based	0
on	0
molecular	0
and	0
genetic	0
factors	0
affecting	0
the	0
disease	0
progression	0
.	0

a	0
retrospective	0
study	0
analyzing	0
the	0
prevalence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
revealed	0
a	0
significant	0
increase	0
in	0
patients	0
with	0
the	0
icd	3
-	4
o	4
code	0
9691	5
over	0
the	0
past	0
decade	0
.	0

the	0
patient	0
was	0
identified	0
with	0
hiv	1
infection	0
based	0
on	0
the	0
icd	3
-	4
9	4
code	0
042	5
.	0

a	0
significant	0
association	0
was	0
found	0
between	0
the	0
brca1	1
gene	0
mutation	0
(	0
omim	3
code	0
113705	5
)	0
and	0
the	0
risk	0
of	0
developing	0
breast	1
cancer	2
.	0

the	0
presence	0
of	0
asthma	1
in	0
children	0
was	0
determined	0
based	0
on	0
the	0
icd	3
-	4
9	4
-	0
cm	0
code	0
493	5
.	0

a	0
recent	0
study	0
investigated	0
the	0
association	0
between	0
psoriasis	1
and	0
the	0
risk	0
of	0
developing	0
comorbidities	0
,	0
focusing	0
primarily	0
on	0
patients	0
with	0
a	0
diagnosis	0
of	0
pustular	0
psoriasis	1
using	0
the	0
icd	3
-	4
10	4
system	0
and	0
its	0
specific	0
code	0
l40	5
.	6
3	6
for	0
this	0
disease	0
subtype	0
.	0

the	0
snomed	3
ct	4
code	0
50711007	5
is	0
linked	0
to	0
the	0
discoid	1
lupus	2
erythematosus	2
phenotype	0
.	0

patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
alopecia	1
areata	2
were	0
identified	0
using	0
icd	3
-	4
10	4
code	0
l63	5
.	0

a	0
total	0
of	0
250	0
patients	0
with	0
obsessive	1
-	2
compulsive	2
disorder	2
(	0
icd	3
-	4
10	4
code	0
f42	5
)	0
were	0
included	0
in	0
this	0
randomized	0
controlled	0
trial	0
.	0

the	0
patient	0
was	0
diagnosed	0
with	0
chronic	1
kidney	2
disease	2
according	0
to	0
the	0
icd	3
-	4
10	4
codes	0
n18	5
.	6
3	6
and	0
n18	5
.	6
9	6
.	0

we	0
identified	0
patients	0
with	0
a	0
diagnosis	0
of	0
sporadic	1
creutzfeldt	2
-	2
jakob	2
disease	2
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
a81	5
.	6
0	6
and	0
subsequent	0
genetic	0
testing	0
.	0

in	0
this	0
study	0
,	0
patients	0
with	0
a	0
diagnosis	0
of	0
schizophrenia	1
according	0
to	0
the	0
dsm	3
-	4
5	4
criteria	0
and	0
295	5
.	6
xx	6
code	0
were	0
included	0
.	0

the	0
study	0
focused	0
on	0
individuals	0
diagnosed	0
with	0
alzheimer	1
'	2
s	2
disease	2
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
g30	5
.	0

in	0
this	0
study	0
,	0
we	0
observed	0
an	0
increased	0
prevalence	0
of	0
systemic	1
lupus	2
erythematosus	2
(	0
sle	0
)	0
in	0
participants	0
with	0
a	0
medical	0
history	0
coded	0
as	0
710	5
in	0
the	0
cd	3
-	4
9	4
classification	0
system	0
.	0

in	0
this	0
study	0
,	0
we	0
examined	0
the	0
prevalence	0
of	0
thrombocytopenic	1
disorders	2
among	0
the	0
patients	0
,	0
predominantly	0
identified	0
by	0
the	0
icd	3
-	4
9cm	4
code	0
287	5
.	6
31	6
,	0
and	0
explored	0
its	0
association	0
with	0
various	0
comorbidities	0
in	0
a	0
large	0
clinical	0
population	0
.	0

according	0
to	0
a	0
recent	0
study	0
,	0
individuals	0
with	0
a	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
(	0
ra	0
)	0
based	0
on	0
the	0
icd	3
-	4
10	4
-	4
cm	4
classification	0
system	0
,	0
specifically	0
code	0
m06	5
.	6
x	6
,	0
were	0
found	0
to	0
be	0
at	0
higher	0
risk	0
for	0
developing	0
certain	0
comorbid	0
conditions	0
compared	0
to	0
those	0
without	0
ra	0
.	0

a	0
recent	0
study	0
investigated	0
the	0
prognosis	0
of	0
patients	0
diagnosed	0
with	0
chronic	1
lymphoid	2
leukemia	2
(	0
cll	0
)	0
utilizing	0
the	0
icd	3
-	4
o	4
-	4
2	4
and	0
icd	3
-	4
o	4
-	4
3	4
coding	0
systems	0
,	0
specifically	0
focusing	0
on	0
the	0
9670	5
code	0
,	0
which	0
corresponds	0
to	0
this	0
particular	0
phenotype	0
.	0

the	0
study	0
included	0
participants	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
borderline	1
personality	2
disorder	2
(	0
icd	3
-	4
10	4
code	0
f60	5
.	6
3	6
)	0
.	0

a	0
recent	0
study	0
found	0
that	0
patients	0
with	0
a	0
migraine	1
phenotype	0
were	0
more	0
likely	0
to	0
be	0
prescribed	0
medications	0
from	0
the	0
atc	3
classification	0
n02cx	5
(	0
other	0
analgesics	0
and	0
antipyretics	0
)	0
for	0
pain	0
management	0
.	0

participants	0
diagnosed	0
with	0
gestational	1
diabetes	2
(	0
icd	3
-	4
10	4
code	0
o24	5
.	6
4	6
)	0
were	0
included	0
in	0
this	0
study	0
if	0
it	0
was	0
their	0
first	0
pregnancy	0
.	0

the	0
omim	3
database	0
indicates	0
that	0
the	0
108300	5
code	0
corresponds	0
to	0
the	0
charcot	1
-	2
marie	2
-	2
tooth	2
disease	2
phenotype	0
.	0

in	0
a	0
recent	0
study	0
,	0
patients	0
with	0
a	0
confirmed	0
diagnosis	0
of	0
rheumatoid	1
arthritis	2
were	0
identified	0
using	0
the	0
clinical	3
modification	4
codes	0
7140	5
from	0
electronic	0
medical	0
records	0
.	0

the	0
research	0
examined	0
patients	0
with	0
hyponatremia	1
according	0
to	0
the	0
icd	3
-	4
10	4
code	0
e87	5
.	6
1	6
.	0

patients	0
in	0
our	0
study	0
were	0
diagnosed	0
with	0
gestational	1
diabetes	2
using	0
the	0
icd	3
-	4
10	4
-	4
cm	4
code	0
o24	5
.	6
4	6
.	0

a	0
study	0
on	0
risk	0
factors	0
for	0
postoperative	0
complications	0
revealed	0
that	0
patients	0
with	0
a	0
history	0
of	0
deep	1
vein	2
thrombosis	2
(	0
icd	3
-	4
9	4
-	4
cm	4
453	5
.	6
6	6
)	0
were	0
more	0
likely	0
to	0
experience	0
adverse	0
outcomes	0
following	0
major	0
orthopedic	0
surgery	0
.	0

in	0
a	0
retrospective	0
study	0
of	0
cancer	0
patients	0
,	0
a	0
significantly	0
high	0
prevalence	0
of	0
non	1
-	2
hodgkin	2
'	2
s	2
lymphoma	2
was	0
found	0
to	0
be	0
associated	0
with	0
the	0
icd	3
-	4
9	4
code	0
202	5
.	6
0x	6
,	0
indicating	0
the	0
importance	0
of	0
precise	0
coding	0
for	0
accurate	0
diagnosis	0
and	0
treatment	0
planning	0
.	0

in	0
a	0
study	0
of	0
patients	0
suffering	0
from	0
peripheral	1
ischaemia	2
,	0
those	0
who	0
underwent	0
femoral	0
-	0
popliteal	0
bypass	0
surgery	0
(	0
cpt	3
code	4
35325	5
)	0
showed	0
a	0
significant	0
improvement	0
in	0
symptoms	0
and	0
quality	0
of	0
life	0
.	0

the	0
prevalence	0
of	0
atopic	1
dermatitis	2
was	0
determined	0
using	0
the	0
icd	3
-	4
10	4
code	0
l20	5
.	0

a	0
retrospective	0
study	0
of	0
patients	0
with	0
a	0
diagnosis	0
of	0
crohn	1
'	2
s	2
disease	2
(	0
under	0
the	0
coding	0
system	0
icd	3
-	4
8	4
and	0
icd	3
-	4
10	4
code	0
group	0
,	0
specifically	0
563	5
.	6
0x	6
)	0
,	0
found	0
that	0
the	0
prevalence	0
of	0
this	0
phenotype	0
was	0
higher	0
in	0
individuals	0
with	0
a	0
family	0
history	0
of	0
inflammatory	0
bowel	0
disease	0
.	0

a	0
recent	0
study	0
reported	0
a	0
high	0
prevalence	0
of	0
infections	1
of	2
other	2
or	2
unspecified	2
organs	2
among	0
hospitalized	0
patients	0
,	0
with	0
the	0
most	0
common	0
diagnosis	0
being	0
registered	0
under	0
the	0
icd	3
-	4
10	4
code	0
b55	5
.	6
0	6
.	0

the	0
genetic	0
analysis	0
focused	0
on	0
individuals	0
with	0
down	1
syndrome	2
identified	0
by	0
the	0
icd	3
-	4
10	4
code	0
q90	5
.	0

the	0
research	0
focused	0
on	0
the	0
alzheimer	1
'	2
s	2
disease	2
diagnosis	0
using	0
the	0
icd	3
-	4
10	4
code	0
g30	5
as	0
the	0
primary	0
inclusion	0
criterion	0
.	0

a	0
recent	0
study	0
found	0
a	0
significant	0
increase	0
in	0
the	0
occurrence	0
of	0
seizures	1
among	0
patients	0
with	0
a	0
clinical	0
diagnosis	0
of	0
icd	3
-	4
10am	4
code	0
r56	5
.	6
8	6
(	0
other	0
and	0
unspecified	0
convulsions	0
)	0
compared	0
to	0
the	0
general	0
population	0
.	0

a	0
retrospective	0
study	0
found	0
a	0
significant	0
association	0
between	0
lower	0
extremity	0
injuries	0
and	0
the	0
occurrence	0
of	0
deep	1
vein	2
thrombosis	2
(	0
dvt	1
)	0
in	0
patients	0
who	0
were	0
coded	0
under	0
the	0
icd	3
-	4
9	4
-	4
d	4
system	0
with	0
the	0
specific	0
code	0
453	5
.	6
40	6
for	0
venous	0
embolism	0
and	0
thrombosis	0
.	0


